Doctoral thesis
The UB Chair of Innovation in Precision Oncology promotes advanced training and the generation of knowledge through the development of doctoral theses in the field of precision oncology.
This section collects information on the doctoral theses completed to date, reflecting the commitment of the Chair to excellent research and the training of new scientific leaders.
Prediction of Therapeutic Benefit in Advanced Hormone Receptor Positive and HER2 Negative Breast Cancer
Author: Olga Martínez Sáez
Defence: 15-12-2021
Qualification: Magna Cum Laude
University: Universitat de Barcelona
Director: Dr. Aleix Prat
Tutor: Dra. Montserrat Muñoz
Olga Martínez, MD, PhD
Medical oncologist specialized in breast cancer
Breast cancer unit
Medical Oncology Service
Institute of Cancer and Blood Diseases (ICAMS)
Clínic Barcelona Comprehensive Cancer Center (4CB)
Translational Genomics and Targeted Therapies in Solid Tumors Group (IDIBAPS)
Identification of biomarkers and strategies that prevent or reduce the use of chemotherapy in early breast cancer
Author: Núria Chic Ruché
Defence: 02-02-2024
Qualification: Magna Cum Laude
University: Universitat de Barcelona
Director: Dr. Aleix Prat y Roger Gomis
Tutor: Dr. Aleix Prat
Núria Chic Ruché, MD, PhD
Medical oncologist specializing in breast cancer
Breast Cancer Unit
Medical Oncology Service
Cancer and Blood Diseases Institute (ICAMS)
Clínic Barcelona Comprehensive Cancer Center (4CB)
Translational Genomics and Targeted Therapies in Solid Tumors Group (IDIBAPS)
Developing exhaustion-resistant CAR-T cells for the treatment of solid tumors
Author: Paula Barbao Carrasco
Defence: 02-12-2024
Qualification: Magna Cum Laude
University: Universitat de Barcelona
Director: Dr. Aleix Prat y Sonia Guedan
Tutor: Dra. Cristina Fillat
Paula Barbao, PhD
Researcher in cellular immunotherapy
Clínic Barcelona Comprehensive Cancer Center (4CB)
Cellular Immunotherapies for Cancer Group (IDIBAPS)
Biological Mechanisms of Response and Resistance to CDK4/6 Inhibitors in Hormone Receptor-Positive HER2-Negative Breast Cancer
Author: Natalia Lorman Carbó
Defence: 11-2025
Qualification: Magna Cum Laude
University: Universitat de Barcelona
Director: Dr. Aleix Prat Aparicio i Fara Brasó Maristany
Tutor: Dr. Aleix Prat
Natalia Lorman Carbó, PhD
PhD in Medicine and Translational Research | Biologist
Clínic Barcelona Comprehensive Cancer Center (4CB)
Translational Genomics and Targeted Therapies in Solid Tumors Group (IDIBAPS)
Reveal Genomics
Peripheral Immune Response Biomarkers Study On Blood And Tissue Samples Collected Over Time
Author: Javier García Corbacho
Defence: 21/05/2025
Qualification: Magna Cum Laude
University: Universitat de Barcelona
Director: Dr. Aleix Prat Aparicio
Tutor: Dr. Carlos Ciudad Gómez
Javier García Corbacho, MD, PhD
Medical Oncologist
Medical Oncology Department
Virgen de la Victoria University Clinical Hospital: Málaga, Andalusia, Spain
Cancer and Blood Diseases Institute (ICAMS)
Barcelona Comprehensive Cancer Center (4CB)
Translational Genomics and Targeted Therapies in Solid Tumors Group (IDIBAPS)
He2-Positive Breast Cancer: Characterization of the Tumor Microenvironment and Development of an Innovative CAR-T Cell Immunotherapy Strategy.
Author: Laura Angelats
Defence: 06/02/2026
Director: Dr. Aleix Prat i Dra. Sonia Guedan.
Tutor: Dr. Aleix Prat
Laura Angelats, MD, PhD
Medical Oncologist at the Hospital Clínic of Barcelona. Specialist in cell therapy (TILs and CAR-T). Principal Investigator of an external affiliated group at TRIP Clinics at IRB Barcelona.
Research Group
Translational Genomics and Targeted Therapies in Solid Tumors
Postdoctoral Researcher (R2A)
Doctoral thesis - David S. Pesantez Coronel
Author: David S. Pesantez Coronel, MD, PhD
Defence: 22/05/2026
Directors: Dr. Aleix Prat and Dr. Tamara Saurí
Tutor: Dra. Tamara Saurí
David S. Pesantez Coronel, MD, PhD
Medical oncologist
Oncology Research & Development, Early Oncology Clinical
AstraZeneca Barcelona, Barcelona, Spain
Cancer and Blood Diseases Institute (ICAMS)
Clínic Barcelona Comprehensive Cancer Center (4CB)
Translational Genomics and Targeted Therapies in Solid Tumors Group (IDIBAPS)
Study of DNA repair pathways in breast cancer with or without germline BRCA1/2 mutations
Author: Adela Rodríguez Hernández, MD, PhD
Defence: 16-06-2026
Qualification: Magna Cum Laude
University: Universitat de Barcelona
Directors: Dr. Aleix Prat and Dr. Barbara Adamo
Tutor: Dr. Aleix Prat
Adela Rodríguez Hernández, MD, PhD
Medical oncologist specialized in breast cancer
Breast Cancer Unit
Medical Oncology Service
Cancer and Blood Diseases Institute (ICAMS)
Clínic Barcelona Comprehensive Cancer Center (4CB)
Translational Genomics and Targeted Therapies in Solid Tumors Group (IDIBAPS)